Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Serum concentrations of organochlorine pesticides and growth among Russian boys.
Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose-escalation phase 1 trial.
Bypassing a bypass: transcatheter aortic valve replacement and percutaneous closure of a regurgitant apical-aortic conduit.
The future of induction chemotherapy for head and neck squamous cell carcinoma.
Hexokinase II may be dispensable for CD4 T cell responses against a virus infection.
See All 13 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Hexokinase II may be dispensable for CD4 T cell responses against a virus infection.
Varanasi SK, Jaggi U, Hay N, Rouse BT. Hexokinase II may be dispensable for CD4 T cell responses against a virus infection. PLoS One. 2018; 13(1):e0191533.
View in:
PubMed
subject areas
Animals
CD4-Positive T-Lymphocytes
Cell Differentiation
Disease Models, Animal
Female
Herpesvirus 1, Human
Hexokinase
Keratitis, Herpetic
Lymphocyte Activation
Mice
Mice, Inbred C57BL
Mice, Knockout
Th1 Cells
Th17 Cells
T-Lymphocytes, Regulatory
authors with profiles
Siva Karthik Varanasi PhD